Mounjaro® 5mg Vial – Tirzepatide InjectionAdvanced Metabolic Support for Glycemic Control & Weight Management Mounjaro 5mg Vial (tirzepatide) is an innovative injectable therapy developed by Eli Lilly and Company, designed to support blood glucose regulation and weight management in adults under medical supervision. As a dual GIP and GLP 1 receptor agonist, it enhances insulin response, reduces appetite, and slows gastric emptyingdelivering a comprehensive approach to metabolic health.

Metabolic Activation

and structural enhancement

Improves moisture retention and restores natural skin luminosity

Modern Product Positioning

Key Benefits

Why Choose Arasti® A Plus (10ml)

with a softer

and under-eye rejuvenation procedures where precise shallow delivery is required

Subtle lifting and contour refinement

and more radiant appearance

Effect Duration: Up to 12–18 months (collagen stimulation dependent)

Body contouring and rejuvenation (off-label use)